Continuous Ambulatory Peritoneal Dialysis Market is expected to reach US$ 1,765.77 Million by 2034

Peritoneal Dialysis Solution Segment Drives Continuous Ambulatory Peritoneal Dialysis Market Growth

According to our new research study named "Continuous Ambulatory Peritoneal Dialysis Market Forecast to 2034 – Global Analysis – by Product Type, End User, and Geography," the market was valued at US$ 1,338.66 million in 2025 and is projected to reach US$ 1,765.77 million by 2034; it is expected to register a CAGR of 3.1% during 2026–2034. The rising prevalence of chronic kidney disease and end-stage renal disease, the growing aging population requiring convenient renal care, and improvements in dialysate formulations and catheter technologies drive the adoption of continuous ambulatory peritoneal dialysis. AI-driven personalized adherence and predictive analytics, simplified user-friendly CAPD systems and accessories, and the growth of hybrid therapy approaches are projected to drive continuous ambulatory peritoneal dialysis market trends in the coming years.

Continuous Ambulatory Peritoneal Dialysis (CAPD) is a home-based dialysis method where the peritoneum filters blood. Dialysate is manually exchanged multiple times daily to remove waste, excess fluids, and maintain electrolyte balance in kidney failure patients. Rising prevalence of chronic kidney disease, increasing preference for home-based treatments, and cost-effectiveness compared to hemodialysis are driving the global continuous ambulatory peritoneal dialysis market growth. Additionally, increasing awareness of early dialysis options, reduced need for hospital visits, and improved patient quality of life propel the market. Technological advancements in dialysis solutions, a rising aging population, improved healthcare access, and supportive government initiatives promoting patient-centric and decentralized renal care services globally are contributing to the rising continuous ambulatory peritoneal dialysis market size.

Continuous Ambulatory Peritoneal Dialysis Market, by Region, 2025 (%)

Source: The Insight Partners Analysis

Continuous Ambulatory Peritoneal Dialysis Market Analysis Based on Segmental Evaluation:

Based on product type, the continuous ambulatory peritoneal dialysis market is segmented into peritoneal dialysis solutions, peritoneal dialysis catheters, peritoneal dialysis transfer sets, and others. The peritoneal dialysis solution segment held a significant continuous ambulatory peritoneal dialysis market share in 2025. The segment shows substantial growth owing to two factors: the rising number of people who develop chronic kidney disease, and the increasing use of home dialysis treatments such as CAPD. Solutions function as vital components that help medical professionals to eliminate harmful substances, surplus body fluids, and maintain essential mineral balance. The industry expands because of new biocompatible glucose-based low-calcium products, which help patients by decreasing health risks through their usage. Rising awareness among patients and healthcare providers, with expanding training programs and favorable reimbursement policies, results in increased demand. The segment gains advantages from the worldwide trend of people choosing affordable, flexible, and convenient renal replacement therapies.

The geographical scope of the continuous ambulatory peritoneal dialysis market report encompasses an assessment of the market performance in North America, Europe, Asia Pacific, South America, Central America, the Middle East, and Africa. North America dominated the continuous ambulatory peritoneal dialysis market share in 2025. The market in the region experiences its primary growth owing to the rising rates of diabetes and hypertension, with the aging population, which causes chronic kidney disease and end-stage renal disease (ESRD) to become more common, boosting the continuous ambulatory peritoneal dialysis market growth.

The patient-friendly benefits of CAPD enable patients to achieve better life quality through its flexible treatment schedule, which enhances their ability to live independently from medical facilities. The implementation of new technologies in dialysis solutions and catheters, with infection control methods, has improved patient security and treatment results, which has led to increased usage of these products. The home-based dialysis therapies in the US and Canada receive support from healthcare infrastructure and reimbursement policies, which make these treatments easier to obtain and less expensive. CAPD functions as a cost-effective treatment solution as it helps patients avoid multiple hospital trips, which reduces their overall medical expenses. The market growth received a boost from two factors: patients and healthcare providers became more aware of home healthcare benefits, and government initiatives supported this medical field. The COVID-19 pandemic accelerated the shift toward home-based treatments, which created a permanent need for CAPD systems throughout North America.

Recent developments include continued national focus on expanding home therapies through education and support programs. The vital organ therapy company Vantive and US Renal Care (USRC), which operates as a US countrywide kidney care provider, established a multi-year strategic agreement in October 2025 to improve home dialysis access and patient care services. USRC has adopted a suite of digitally enabled Vantive PD products and advanced support services designed to strengthen patient care, streamline clinical workflows, and improve the home dialysis experience. Similarly, the privately held company Simergent, dedicated to developing kidney failure treatments, received 510(k) clearance from the US Food and Drug Administration (FDA) for its Archimedes automated peritoneal dialysis system, which treats patients with ESKD in clinical and home settings. The treatment programs enable additional patients to receive home-based ESKD care, which enhances their daily routine and reduces the impact of kidney failure. Hence, the above-mentioned factors collectively support the growth of the global continuous ambulatory peritoneal dialysis market.

Baxter International Inc, Fresenius Medical Care AG & Co KGaA, Terumo Corp, Medtronic Plc, JMS Co., Ltd., Polymedicure, Advin Health Care Pvt. Ltd., Utah Medical Products Inc, Mitra Industries Pvt. Ltd., and Newsol Technologies Inc. are among the leading companies profiled in the continuous ambulatory peritoneal dialysis market report.

Based on product type, the continuous ambulatory peritoneal dialysis market is divided into peritoneal dialysis solution, peritoneal dialysis catheters, peritoneal dialysis transfer sets, and others. By end user, the market is segmented into in-center dialysis settings and home care settings. Geographically, the continuous ambulatory peritoneal dialysis market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East and Africa (Saudi Arabia, South Africa, the UAE, and the Rest of Middle East and Africa), and South and Central America (Brazil, Argentina, and the Rest of South and Central America).

Contact Us

Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com